Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 12, 2016America's Leading National Consumer Research Survey Ranks ACT Advanced Care #1 in "Oral Care" Category
-
Feb 2, 2016Six researchers each receive $1.625 million in "Pathway to Stop Diabetes®" awards
-
Dec 11, 2015Praluent® is the only PCSK9 inhibitor preferred across UnitedHealth Group formularies, including OptumRx and UnitedHealthcare Commercial, Medicare, and Managed Medicaid formularies
-
Dec 1, 2015New 24 and 32-Packs Designed to Manage Dosage Regimens for both Latent and Active Tuberculosis
-
Nov 10, 2015- 74 percent of patients reached their LDL cholesterol goals on 75 mg dose; Of the remaining patients whose dose was adjusted to 150 mg, most achieved their goal -
-
Nov 8, 2015- Data Show Significant Improvement in Signs and Symptoms and Physical Function in Rheumatoid Arthritis Patients who were Inadequate Responders to or Intolerant of TNF-Alpha Inhibitors (TNF-IR) -
-
Aug 31, 2015- Will work together on new digital technology and tools for diabetes -
-
Jun 30, 2015Sanofi and Regeneron Engage Academy Award® Winning Documentarian to Capture Behind-the-Scenes Look at Life with an Invisible Condition
-
Mar 18, 2015Allergy sufferers are encouraged to share the #HappySmells they experience this season
-
Feb 11, 2015America's Leading National Consumer Research Survey Ranks Gold Bond Products #1 in "U.S. Body Comfort and Relief" and "U.S. Skincare" Categories
-
Nov 18, 2014IcyHot SmartRelief System Provides Physical Therapist-Trusted TENS Technology for Persistent, Chronic Back Pain Relief That Starts at the Touch of a Button
-
Nov 11, 2014- Dupilumab Demonstrated Improvement in Lung Function, Reductions of Severe Exacerbations -
-
Aug 13, 2014- Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older -
-
Jul 30, 2014- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor -
-
Apr 1, 2014New investigational PCSK9 inhibitor shown to significantly reduce LDL-C among Japanese patients
-
Feb 4, 2014First and only medicine in its class approved for over-the-counter use that provides 24 hour relief of the full range of nasal allergy symptoms including nasal congestion
-
Dec 19, 2013- Collaboration represents the first time the ACC’s PINNACLE Registry Research Alliance will be used for clinical trial recruitment -
-
Oct 11, 2013- Nasal Spray Treats Adults and Children with Seasonal and Year-Round Nasal Allergies -
-
Aug 20, 2013- Majority of Survey Respondents Reported They or Their Child Experienced a Severe Allergic Reaction While Traveling -